Table 1. List of primers used in HIV-1 genotypic drug-resistance testing.
Target region | Amplicon | Primers | ||||
Size (bp) | Positiona | Reaction | Direction | Name | Nucleotide sequence (5′ to 3′) | |
Protease | 424 | 2,168 to 2,591 | RT-PCR | Forward | DRPRO5 | AGA CAG GYT AAT TTT TTA GGG A |
Reverse | DRPRO2L | TAT GGA TTT TCA GGC CCA ATT TTT GA | ||||
Nested PCR | Forward | DRPRO1M | AGA GCC AAC AGC CCC ACC AG | |||
Reverse | DRPRO6 | ACT TTT GGG CCA TCC ATT CC | ||||
Reverse transcriptase | 838 | 2,510 to 3,347 | RT-PCR | Forward | DRRT1L | ATG ATA GGG GGA ATT GGA GGT TT |
Reverse | DRRT4L | TAC TTC TGT TAG TGC TTT GGT TCC | ||||
Nested PCR | Forward | DRRT7L | GAC CTA CAC CTG TCA ACA TAA TTG G | |||
Reverse | DRRT6L | TAA TCC CTG CAT AAA TCT GAC TTG C |
bp, base pairs; PCR, polymerase chain reaction; and RT-PCR, reverse transcription and polymerase chain reaction.
Amplicon positions in the reference HIV-1 HXB2 sequence are represented.